Adocia (ADOCY)
11.80
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Adocia Shareholders Equity (Quarterly): -7.642M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.642M |
| June 30, 2023 | -20.03M |
| June 30, 2023 | -20.03M |
| December 31, 2022 | -13.91M |
| June 30, 2022 | -4.589M |
| June 30, 2022 | -4.589M |
| December 31, 2021 | -15.64M |
| June 30, 2021 | -4.945M |
| June 30, 2021 | -4.945M |
| December 31, 2020 | 7.791M |
| June 30, 2020 | 18.36M |
| June 30, 2020 | 18.36M |
| December 31, 2019 | 31.41M |
| June 30, 2019 | 37.30M |
| June 30, 2019 | 37.30M |
| December 31, 2018 | 52.45M |
| June 30, 2018 | 55.55M |
| June 30, 2018 | 55.55M |
| December 31, 2017 | 44.22M |
| Date | Value |
|---|---|
| June 30, 2017 | 58.46M |
| June 30, 2017 | 58.46M |
| December 31, 2016 | 45.21M |
| June 30, 2016 | 49.57M |
| June 30, 2016 | 49.57M |
| December 31, 2015 | 51.44M |
| June 30, 2015 | 44.19M |
| June 30, 2015 | 44.19M |
| December 31, 2014 | 3.046M |
| June 30, 2014 | 18.94M |
| June 30, 2014 | 18.94M |
| December 31, 2013 | 26.42M |
| June 30, 2013 | 24.57M |
| June 30, 2013 | 24.57M |
| December 31, 2012 | 30.45M |
| June 30, 2012 | 33.99M |
| June 30, 2012 | 33.99M |
| December 31, 2011 | 5.607M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-20.03M
Minimum
Jun 2023
37.30M
Maximum
Jun 2019
3.613M
Average
-4.589M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 111.65M |
| Cellectis SA | 84.70M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 75.11M |
| Innate Pharma SA | 57.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.59M |
| Total Liabilities (Quarterly) | 35.23M |
| Debt to Equity Ratio | -0.8315 |
| Current Ratio | 1.020 |
| Net Debt Paydown Yield | 5.02% |